Mazor Robotics Ltd., the developer of Renaissance™, an innovative surgical guidance system and its complementary products, announced today that it has received its first order for a Renaissance system from Cordamed Biomedical Engineering Inc., its distribution partner in Turkey. This represents the first Renaissance system order in Turkey, and Cordamed will install the system at a prominent hospital in Istanbul.
“Our strategy of working with distributors is demonstrating tangible results, allowing us to expand our presence in key markets,” commented Ori Hadomi, Mazor’s Chief Executive Officer. “Our Renaissance system enables hospitals to improve patient care with a leading technology, thus raising the standard of the care.”
“The Cordamed team is highly skilled and motivated to ensure the healthcare system throughout Turkey is utilizing the latest technologies to provide better surgery outcomes,” commented Bayram Kose, Chief Executive Officer of Cordamed. “The clinical success to date of the Renaissance system could create additional opportunities in Turkey as healthcare facilities seek to raise the standard of care.”
Cordamed has been focused on the minimally invasive surgery (MIS) market since 2006, representing a new generation of medical device companies that have developed leading technology products. Through its analytical experiences in biomedical engineering and a highly experienced post-sales assistance team, it has exclusive distribution rights for most of the robotic surgical systems that improve the quality of healthcare services standards in Turkey.
Mazor Robotics is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 35,000 implants worldwide. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology.